1. Hernandez-Salazar P, Ortiz-Rodriguez A, Garcia-Fuentes NB, Martinez-Salazar MF, et al.
   Physical activity, anxiety, depression, and adherence to antiretroviral therapy in people with HIV.
   AIDS Res Hum Retroviruses 2023.
   


2. Lea AN, Leyden WA, Sofrygin O, Marafino BJ, et al.
   Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
   Clin Infect Dis 2023.
   


3. Del Amo J.
   Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 (COVID-19).
   Clin Infect Dis 2023.
   


4. Imp BM, Levine T, Satre DD, Skarbinski J, et al.
   Influenza Vaccination Uptake and Associated Factors Among Adults With and Without HIV in a Large, Integrated Health Care System.
   Clin Infect Dis 2023.
   


5. Schapiro JM.
   Dynamics of HIV-1 A6 variant transmissions between Poland and Ukraine.
   Clin Infect Dis 2023.
   


6. Serwin K, Chaillon A, Schiebe K, Urbanska A, et al.
   Circulation of HIV-1 A6 variant in the East border of European Union - dynamics of the virus transmissions between Poland and Ukraine.
   Clin Infect Dis 2023.
   


7. Rubin R.
   Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
   JAMA 2023.
   


8. Rosenthal EM, Patterson W, Chicoine J, Dorabawila V, et al.
   COVID-19 vaccination and hospitalization among persons living with diagnosed HIV in New York State.
   J Acquir Immune Defic Syndr 2023.
   


9. Patten G, Sipambo N, Technau KG, Euvrard J, et al.
   Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa.
   J Acquir Immune Defic Syndr 2023;92:273-280.
   


10. Wang T, Zheng L, Zhao Q, Yao Y, et al.
    Parainfluenza virus 5 is a next-generation vaccine vector for human infectious pathogens.
    J Med Virol 2023.
    


11. Rwibasira GN, Dzinamarira T, Remera E, Malamba SS, et al.
    Engagement in HIV continuum of care: another step needed to close the gap towards UNAIDS 90-90-90 targets among younger men in Rwanda.
    J Med Virol 2023.
    


12. Rzymski P, Szuster-Ciesielska A, Dzieciatkowski T, Gwenzi W, et al.
    mRNA vaccines: The future of prevention of viral infections?
    J Med Virol 2023.
    


13. Mitja O, Alemany A, Marks M, Lezama Mora JI, et al.
    Mpox in people with advanced HIV infection: a global case series.
    Lancet 2023.
    


14. .
    HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation.
    Nat Med 2023.
    


15. Johnson J, Killelea A, Farrow K.
    Investing in National HIV PrEP Preparedness.
    N Engl J Med 2023;388:769-771.
    


16. Olbrich L, Nliwasa M, Sabi I, Ntinginya NE, et al.
    Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease (RaPaed-TB): A Diagnostic Accuracy Study for Pediatric Tuberculosis.
    Pediatr Infect Dis J 2023.
    


17. Moran JA, Ranjan A, Hourani R, Kim JT, et al.
    Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal.
    Virology 2023;581:8-14.
    

Display articles in

• Abstract format
• Medline format